The acquisition is effective immediately and financial terms of the transaction are not being disclosed.
Knovel is a Web-based application integrating technical information with analytical and search tools to drive innovation and deliver answers engineers can trust. Knovel users include thousands of engineers and applied scientists worldwide. Knovel has more than 700 customers worldwide including 74 of the Fortune 500 companies, five of the Top 10 Constituents on the FTSE 100 Index and more than 400 leading universities. Founded in 2000, Knovel is a private company headquartered in New York City. For more information, visit http://www.knovel.com or call +1-866-240-8174.
About ElsevierElsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, Reaxys, ClinicalKey and Mosby's Nursing Suite, which enhance the productivity of science and health professionals, and the SciVal suite and MEDai's Pinpoint Review, which help research and health care institutions deliver better outcomes more cost-effectively. A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world-leading a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange). Media contacts Amy Burnis Director, Marketing Communications Knovel +1-617-803-8344 email@example.com Christopher Capot Director, Corporate Relations Elsevier +1-212-633-3164 firstname.lastname@example.org SOURCE Elsevier